Health

When Ashkaan asks about his health, diet, supplements, or biomarkers: 1. **Consider his genetic context** - APOE e4/e4 carrier with specific cardiovascular and cognitive risk factors 2. **Reference current medications and supplements** - check for interactions before recommending additions 3. **Apply his dietary framework** - Mediterranean-plus diet, low saturated fat, MUFA-forward 4. **Use evidence-based standards** - cite evidence levels (strong/moderate/weak) when making recommendations 5. **Track biomarker targets** - he has specific goals for ApoB, LDL-P, hs-CRP 6. **Update this file** when significant changes occur (new labs, supplement changes, diagnoses) ### Key Decision Factors - APOE e4/e4 = aggressive cardiovascular and cognitive risk management - LDL-C responds strongly to dietary saturated fat - Benefits from EPA > DHA for omega-3s - Current focus: ApoB optimization, inflammation reduction ---

**Last Updated:** 2026-01-24 ### Genetic Profile **Full details:** [genome/](genome/) **Source:** 23andMe v5 (2018-02-20) | Marker | Status | Implications | |--------|--------|--------------| | APOE | e4/e4 | Highest genetic risk for Alzheimer's; aggressive lipid management needed | | Lp(a) | 23 nmol/L | LOW RISK (<75) - favorable genetic marker | ### Biomarker Targets | Biomarker | Current | Date | Target | Status | |-----------|---------|------|--------|--------| | ApoB | 101 mg/dL | 2025-12-18 | <80 mg/dL | Above target (↓16) | | LDL-P | 1,946 nmol/L | 2025-12-18 | <1000 nmol/L | Above target (↓349) | | hs-CRP | 0.7 mg/L | 2025-12-18 | <1 mg/L | ✓ OPTIMAL | | LDL-C | 122 mg/dL | 2025-12-18 | <100 mg/dL | Above target (↓55) | | TSH | 2.99 mIU/L | 2025-12-18 | 1-2 optimal | ✓ Normal (↓1.3) | | 25(OH) Vitamin D | 122 ng/mL | 2025-10-10 | 40-80 ng/mL | High (reduce dose) | | Ferritin | 339 ng/mL | 2025-10-10 | 50-150 ng/mL | Elevated | | Mercury | 20 mcg/L | 2025-10-10 | <5 mcg/L | HIGH - reduce fish | **Full blood work history:** [/tools/ashkaan/bloodwork/](bloodwork/index.md) ### Current Supplement Stack **Full details:** [supplements.md](supplements.md) - complete ingredient breakdown with forms, amounts, and % DV | Supplement | Dose | Primary Purpose | |------------|------|-----------------| | Multivitamin | 1x | 22 vitamins/minerals (see supplements.md) | | Turmeric Curcumin with BioPerine | 2 caps | Anti-inflammatory | | Beta-Sitosterol with CardioAid-S | 2 caps | Cholesterol management | | Berberine HCl with Ceylon Cinnamon | 2 caps | Metabolic health | | Vitamin K2 MK-7 | 1 cap | Calcium metabolism | | Glucosamine Chondroitin MSM | 1 cap | Joint health | | Ultra Omega 3 Fish Oil | 1 cap | Cardiovascular, anti-inflammatory | | Coenzyme Q10 | 1 cap | Cellular energy | | Magnesium Glycinate (Chelated) | 2 tabs (270mg) | Sleep quality | | Creatine Monohydrate | 5g | Muscle, strength, cognition | | Beta-Alanine | 2g | Muscle endurance | **Daily Totals:** D3: 2000 IU | K (K1+K2): 180 mcg | EPA: ~733 mg | DHA: ~282 mg ### Current Prescription | Medication | Dose | Purpose | |------------|------|---------| | Finasteride | 1mg | Hair loss prevention | ### Eyes **Full details:** [eyes.md](eyes.md) **Current Rx (2025-08-30):** OD -1.50/-0.50 | OS -1.75/-0.50 | PD 60.0 **Trend:** Left eye worsening, right astigmatism increasing ### Procedures **Full details:** [procedures.md](procedures.md) **2023-03-31:** Balloon sinuplasty + turbinate reduction (Dr. Cohen, West Hills) - improved nasal breathing ### Dental **Full details:** [dental.md](dental.md) **Status (2017-03-16):** Type II Mild Periodontitis | Bacterial risk: LOW | 0 high-risk pathogens ### Allergies **Full details:** [allergies.md](allergies.md) **Class 2 (Moderate):** Aspergillus mold, Cat, Olive tree, Walnut tree, Mugwort **Class 1 (Low):** Dog ### Gut Microbiome **Full details:** [gut.md](gut.md) **Status (2017-2018):** Normal diversity, all pathogens negative **Persistently Low:** Akkermansia muciniphila, Lactobacillus, Oxalobacter formigenes **Note:** Data is 7+ years old; consider retesting if gut optimization is a priority ### Cardiovascular **Full details:** [heart.md](heart.md) **CT Calcium Score (2020-10-23):** 0 (0th percentile) - No detectable coronary artery calcification **Arterial Health (2025-11-14):** LOW RISK - All metrics within normal range **Arterial Stiffness:** Normal for age (Augmentation Index 18%, normal 4-27) **Note:** Excellent findings despite APOE e4/e4 genetic risk ### Fertility **Full details:** [fertility.md](fertility.md) **Latest (2024-10-28):** Concentration 125.8 M/mL | Progressive Motility 51% | Normal Forms 9% **Status:** GOOD fertility parameters, above WHO reference ranges **Trend:** Some decline from 2018 (age 32→39) but values remain normal/excellent ### Vaccinations | Vaccine | Dates | Notes | |---------|-------|-------| | COVID-19 | April 2021 | Pfizer 2-dose series (Forum clinic) | | Hepatitis B | 1996, 2001 | 3-dose series (12/5/96, 8/30/01, 11/7/01) | | MMR | 1987, 1996 | 2 doses (1/30/87, 12/5/96) | --- ### Dietary Framework **Template:** Mediterranean-plus (APOE e4/e4 optimized) | Principle | Target | |-----------|--------| | Fat distribution | 60-70% MUFA, 20% omega-3, <10% saturated | | Primary fats | EVOO, avocado, almonds, walnuts | | Proteins | Fatty fish 2-3x/week, skinless poultry, legumes | | Fiber | ≥10g soluble/day (psyllium, oats, flax) | | Plant sterols | 2g/day | | Red meat | ≤2 servings/week | | Avoid | Coconut oil, butter, cheese, seed oils | ### Body Composition **Full details:** [body-composition.md](body-composition.md) **Latest (2024-03-05):** 27.6% body fat | 122.5 lbs lean | 2.27 lbs VAT **Trend:** Recomposition working (+lean, -fat), but VAT increasing **Smart Scale (Current):** 167.4 lbs | 13% BIA (trend tracking only) ### Sleep **Full details:** [sleep.md](sleep.md) **Average:** 6.8 hours | 12% deep | 21% REM | 33 min awake **Status:** Below 7-hour target; deep sleep below optimal **Last 14 days:** 6.9 hours average ### Active Health Goals 1. **Primary:** Achieve ApoB <80 mg/dL through diet + supplements (now 101, was 117 - progressing) 2. **Secondary:** ✓ ACHIEVED - hs-CRP at 0.7 mg/L (goal was <1 mg/L) 3. **Tertiary:** Optimize sleep quality (7+ hours, minimize mid-night waking) 4. **Body Comp:** Reduce body fat to <20% while maintaining lean mass ---

### Testing Framework | Phase | Timeline | Focus | |-------|----------|-------| | Baseline | Initial | Full panel including genetic markers (APOE, Lp(a)) | | Intervention Check | 12 weeks | Track response to diet/supplement changes | | Medication Titration | 8-12 weeks after starting | Assess drug efficacy and side effects | | Maintenance | Every 6-12 months | Ongoing monitoring once targets achieved | ### 12-Week Retest Panel - ApoB or LDL-P (primary target) - Standard lipid panel (TC, LDL-C, HDL-C, TG) - hs-CRP (repeat 2x at least 2 weeks apart, only when well) - 25(OH)D + Calcium - Ferritin + Iron/TIBC → calculate TSAT - CMP, TSH, HbA1c + Fasting Glucose + Fasting Insulin - Blood Mercury (if high fish consumption) - ALT/AST (if using curcumin) ### Lab Test Categories | # | Category | Tests | |---|----------|-------| | 1 | Hematology | CBC, RBC indices | | 2 | Inflammation | CRP, ESR, Homocysteine | | 3 | Glucose | Glucose, A1c, Insulin | | 4 | Lipids | Cholesterol, LDL-P, ApoB | | 5 | Iron | Iron, TIBC, Ferritin, TSAT | | 6 | Kidney | Electrolytes, BUN, Creatinine, eGFR | | 7 | Liver | ALT, AST, Albumin, Bilirubin | | 8 | Thyroid | TSH, T4, T3 | | 9 | Vitamins | D3, B12, Folate, Zinc | ### APOE e4/e4 Medication Escalation Path If diet + supplements don't achieve targets: 1. Statin (rosuvastatin 10-20 mg OR atorvastatin 20-40 mg) 2. Add ezetimibe 10 mg (additional 18-25% LDL-C drop) 3. PCSK9 inhibitor or Inclisiran if still needed 4. Icosapent ethyl 2g 2x/day if TG 150-499 despite statin ### Restaurant Navigation **Wingstop (Low Carb):** - Best: Plain Classic Wings, Garlic Parmesan, Louisiana Rub, Lemon Pepper - Avoid: Boneless wings (breaded), sticky sauces, fries - Order: 10 Classic Wings (dry rub) + celery = ~60g protein, ~10g carbs **Gracias Madre (Plant-Based):** - Best: Oaxaca Bowl (~23-24g protein), Crispy Garlic Chipotle Tofu - Strategy: Bowl + protein side for maximum protein ### Sleep Optimization **Magnesium for Sleep:** - Form: Magnesium Glycinate (bisglycinate) preferred - Dose: 200-400mg elemental, 30-60 min before bed - Optional: Add 3g glycine powder for deeper effect - Avoid: Magnesium oxide (poor absorption) ### Health Reflection Framework **13-Component Hierarchy (Priority Order):** 1. Restorative Sleep & Recovery 2. Stress Regulation & Mental Clarity 3. Metabolic Nourishment 4. Strength & Functional Movement 5. Emotional Regulation & Self-Compassion 6. Spiritual Grounding / Purpose Alignment 7. Social Belonging & Play 8. Hormone Balance 9. Cardiovascular Conditioning 10. Flexibility & Mobility 11. Preventive Care & Biomarkers 12. Immune Resilience 13. Environmental & Digital Hygiene ---

- Review supplement stack with physician annually - APOE e4/e4 status means standard "healthy" recommendations may not apply - Curcumin at current doses requires periodic liver enzyme monitoring (ALT/AST) - Consider genetic counseling for Alzheimer's risk management strategies ### Interventions Considered & Declined | Intervention | Date | Rationale for Declining | |---|---|---| | Peptides (CJC-1295/Ipamorelin, BPC-157, Semax) | 2026-02-18 | Insufficient human evidence. CJC-1295/Ipamorelin: Phase I/II only, combination never formally studied, insulin resistance risk. BPC-157: near-zero human RCTs, single-lab problem (Sikiric/Zagreb), angiogenesis concern. Semax: Russian approval only, no Western replication. Current stack (creatine, berberine, etc.) has stronger evidence base. Revisit if RCT data improves. |